On January 27, 2026, Genenta Science S.p.A. reported expected cash and equivalents of approximately $33 million as of December 31, 2025, up from $17.7 million on June 30, 2025, but stated these figures are preliminary and subject to audit changes.
AI Assistant
GENENTA SCIENCE SPA
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.